-
Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives Consensus Rating of "Moderate Buy" from Analysts
Source: Buzz FX / 23 Nov 2024 06:09:09 America/New_York
Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeat November 23, 2024 Share Link copied to clipboard. Shares of Regulus Therapeutics Inc.
Read more...